miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6

Autor: Weiwei Jiang, Liyong Pu, Weibing Tang, Yeting Lu, Qing-Feng Ni, Wen-Zhou Ding, Liang-Liang Kong, Lianbao Kong, Guo-Qing Liu
Rok vydání: 2014
Předmět:
Male
lcsh:Medicine
Gene Expression
Pharmacology
Monocytes
White Blood Cells
RNA interference
Animal Cells
Molecular Cell Biology
lcsh:Science
Receptor
Immune Response
Cellular Stress Responses
Liver injury
Innate Immune System
Multidisciplinary
Cell Death
Chemistry
Toll-Like Receptors
Animal Models
Cell Hypoxia
Interleukin-1 Receptor-Associated Kinases
Liver
Cell Processes
Reperfusion Injury
Cytokines
Epigenetics
medicine.symptom
Signal transduction
Cellular Types
Signal Transduction
Research Article
Immune Cells
Immunology
Down-Regulation
Inflammation
Mouse Models
Research and Analysis Methods
Proinflammatory cytokine
Cell Line
Immunomodulation
Model Organisms
In vivo
medicine
Genetics
Animals
Hepatic Insufficiency
Antibody-Producing Cells
TNF Receptor-Associated Factor 6
Blood Cells
Biology and life sciences
Macrophages
lcsh:R
Immunity
Immunoregulation
Cell Biology
Molecular Development
medicine.disease
Mice
Inbred C57BL

MicroRNAs
Apoptosis
Immune System
lcsh:Q
Clinical Immunology
Reperfusion injury
Developmental Biology
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 7, p e101530 (2014)
ISSN: 1932-6203
Popis: A critical role of the Toll-like receptor(TLR) and its downstream molecules, including IL-1 receptor-associated kinase 1(IRAK1) and tumor necrosis factor receptor- associated factor 6(TRAF6), in the pathogenesis of liver ischemia/reperfusion (I/R) injury has been documented. Recently a microRNA, miR-146a, was identified as a potent negative regulator of the TLR signaling pathway. In this study, we investigated the role of miR-146a to attenuate TLR signaling and liver I/R injury in vivo and in vitro. miR-146a was decreased in mice Kupffer cells following hepatic I/R, whereas IRAK1 and TRAF6 increased. Overexpression of miR-146a directly decreased IRAK1 and TRAF6 expression and attenuated the release of proinflammatory cytokines through the inactivation of NF-κB P65 in hypoxia/reoxygenation (H/R)-induced macrophages, RAW264.7 cells. Knockdown experiments demonstrated that IRAK1 and TRAF6 are two potential targets for reducing the release of proinflammatory cytokines. Moreover, co-culture assays indicated that miR-146a decreases the apoptosis of hepatocytes after H/R. In vivo administration of Ago-miR-146a, a stable version of miR-146a in vivo, protected against liver injury in mice after I/R via inactivation of the TLR signaling pathway. We conclude that miR-146a ameliorates liver ischemia/reperfusion injury in vivo and hypoxia/reoxygenation injury in vitro by directly suppressing IRAK1 and TRAF6.
Databáze: OpenAIRE